SANOFI-AVENTIS (EPA:SAN)

BRIEF

published on 12/23/2025 at 07:05, 1 month 7 days ago

Sanofi and Regeneron's Dupixent Gains Approval in Japan for Young Asthma Patients

Sanofi Dupixent Japan Approval Regeneron Asthma
PRESS RELEASE

published on 12/23/2025 at 07:00, 1 month 7 days ago

Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
Sanofi and Regeneron's Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma, showing significant reduction in exacerbations and improved lung function in phase 3 studies

Sanofi Phase 3 Study Dupixent Regeneron Bronchial Asthma
BRIEF

published on 12/22/2025 at 18:40, 1 month 7 days ago

Sanofi Provides Update on Voting Rights and Shares for November 2025

Voting Rights Treasury Shares Issued Shares Sanofi November 2025
PRESS RELEASE

published on 12/22/2025 at 18:35, 1 month 7 days ago

Sanofi: Information concerning the total number of voting rights and shares - November 2025
Sanofi discloses total voting rights and shares under French regulations. Details available on website. Contact Investor Relations Department for more information

Voting Rights Shares French Regulations Investor Relations Sanofi
BRIEF

published on 12/19/2025 at 20:26, 1 month 10 days ago

Sanofi signs an agreement with the United States to reduce the cost of medicines

Biopharmaceutical Innovation Sanofi Affordable Medications Trump Deal Investments In The United States
BRIEF

published on 12/19/2025 at 20:26, 1 month 10 days ago

Sanofi Agreement with US Government to Lower Medicine Costs

Innovation Healthcare Savings US Government Sanofi Agreement Medicine Costs
PRESS RELEASE

published on 12/19/2025 at 20:21, 1 month 10 days ago

Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
Sanofi agrees with US government to lower medicine costs, support innovation, and US manufacturing. Agreement meets President Trump's requests, ensuring affordable access for American patients

Innovation Manufacturing Sanofi US Government Medicine Costs
BRIEF

published on 12/17/2025 at 07:35, 1 month 13 days ago

Sanofi publishes the document "Q4 2025 Quick Reference Guide"

Financial Results Investors Sanofi Q4 2025 Modeling
BRIEF

published on 12/17/2025 at 07:35, 1 month 13 days ago

Sanofi Releases Q4 2025 Aide Mémoire

Sanofi Financial Modeling Aide Mémoire Q4 2025 Forward-Looking
PRESS RELEASE

published on 12/17/2025 at 07:30, 1 month 13 days ago

Press release: Availability of the Q4 2025 Aide memoire
Sanofi announces availability of Q4 2025 Aide memoire on the company's website for financial modeling purposes. Q4 2025 results to be published on January 29, 2026

Sanofi Results Aide Mémoire Financial Modelling Q4 2025

Published on 01/30/2026 at 08:35, 3 hours 24 minutes ago

Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 3 hours 59 minutes ago

Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 9 hours 44 minutes ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 11 hours 59 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 12 hours 59 minutes ago

PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A

View all ACCESSWIRE

Published on 01/30/2026 at 10:30, 1 hour 29 minutes ago

ASTA ENERGY SOLUTIONS AG SUCCESSFULLY COMPLETES IPO
Published on 01/30/2026 at 10:00, 1 hour 59 minutes ago

Appointment of Managing Director of Tradegate BSX
Published on 01/30/2026 at 09:00, 2 hours 58 minutes ago

Original-Research: 123fahrschule SE (von NuWays AG): BUY
Published on 01/30/2026 at 09:00, 2 hours 58 minutes ago

Original-Research: q.beyond AG (von NuWays AG): BUY
Published on 01/30/2026 at 09:00, 2 hours 59 minutes ago

Official List Notice

View all EQS

Published on 01/30/2026 at 08:00, 3 hours 59 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 17 hours 59 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 18 hours 14 minutes ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 18 hours 14 minutes ago

Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 17:40, 18 hours 19 minutes ago

ALTEN: Annual revenue 2025

View all LES ECHOS COMFI WIRE

News